Delivery Order HHSN272201700020I-75N93021F00003

Award Date 9/7/21
Potential Completion Date 7/30/23
Potential Value $1.2M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Taiwan
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Pharmacology Discovery Services Taiwan, LTD. was awarded a firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The $1,628,062 delivery order is for the company to provide therapeutic testing in murine models of bacterial thigh, lung and peritonitis infections, as described in Task A42 of the original solicitation. Performance will take...
Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,197,620 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. Through this vehicle, the Taiwanese contractor will provide preclinical infectious disease modeling services to NIAID through August 2023 to support the agency's research into mechanisms of disease and therapeutic testing....
Pharmacology Discovery Services Taiwan, LTD. was awarded a $336,528 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for the company to supply murine models of urinary tract infections caused by antibiotic-resistant bacteria, in support of NIAID's major program focused on preclinical research of infectious disease mechanisms and...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,272,675.00 firm fixed price delivery order to Pharmacology Discovery Services Taiwan, LTD., a Taiwanese for-profit organization. This delivery order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. The work focuses on providing NIAID with therapeutic testing...
This federal contract award to Pharmacology Discovery Services Taiwan, LTD. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The $754,505.00 firm fixed price delivery order funds the provision of murine (mouse) models of bacterial infections to support NIAID's infectious disease research program. This includes...
This federal contract award to Pharmacology Discovery Services Taiwan, LTD. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $1,193,205.00 firm fixed price delivery order is for the provision of murine (mouse) models of urinary tract infections caused by antibiotic-resistant bacteria. This work supports NIAID's Preclinical Models of Infectious Diseases program, an ongoing...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company. The contract, valued at $1,239,019.00, is a delivery order issued under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Pharmacology Discovery Services Taiwan, Ltd., a Taiwanese for-profit organization. The contract, valued at $1,797,620.00, is a delivery order issued under the larger NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. Under this contract,...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $332,878 delivery order to Pharmacology Discovery Services Taiwan, LTD under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. This cost-plus-award-fee contract will provide pre-clinical models of infectious diseases to support research efforts at NIAID through September 1, 2021. As part of its mission to conduct and support research on infectious, immunologic, and...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a Taiwanese for-profit company. The $1,872,088.00 firm fixed price delivery order is part of the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery Services Taiwan will provide NIAID with a mouse model of...

Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,170,062.04 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. This delivery order funds the prime contractor's work providing preclinical disease modeling services to support NIAID's infectious disease research mission. Specifically, Pharmacology Discovery Services Taiwan will supply murine and other animal models of bacterial infections and urinary tract infections caused by antibiotic-resistant bacteria to enable testing of potential treatments. No subcontractors or set aside designation were specified. The delivery order has a completion date of July 30, 2023 and was awarded on a firm fixed price basis by the Department of Health and Human Services' National Institutes of Health through the NIAID.

Generated 2/7/24, 10:58 AM